Skip navigationThe Wellcome Trust Advanced Courses and Scientific Conferences

 
Questions or Queries

Telephone
:
+44 (0) 1223 495100

Email:

scientificconferences@ hinxton.wellcome.ac.uk

Home

Travel Information

Abstract Guidelines

Venue Details

Past Conferences

Sponsorship Opportunities

Terms and Conditions
 






Biomarkers for Brain Disorders: Challenges and Opportunities 
27 February - 2 March 2011
Wellcome Trust Conference Centre, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK

This event has has now expired. To be re-directed to the 2013 conference page, please click here.



REGISTRATION HAS NOW CLOSED DUE TO REACHING MAXIMUM CAPACITY
Please email lucy.criddle@hinxton.wellcome.ac.uk to be added to the waiting list


Summary

The discovery and validation of biomarkers in neurological and neurodegenerative diseases is an important challenge for early diagnosis of disease and for the development of therapeutics.This new Wellcome Trust Scientific Conference will bring together leading neuroscientists from academia and industry involved in genomics, proteomics, diagnostics, imaging and regulatory affairs.

The meeting will discuss methodological aspects of biomarker identification across a spectrum of psychiatric and neurodegenerative disorders, strategies for diagnostic assay development and pathways for regulatory approval. Specific attention will be given to results from consortia such as the Alzheimer Disease Neuroimaging Initiative (ADNI), and to the prioritization of approaches not yet included in large consortia efforts, such as functional measures of brain activity captured by fMRI or electrophysiological recordings.

Topics
Strategies for building large biorepositories
Technologies for molecular profiling and biomarker discovery: is multimodality the key?
Building and validating biochemical and functional assays
Measuring brain function in health and disease
Clinical studies of biomarkers in neurological disease (e.g. Amyotrophic lateral sclerosis, Multiple sclerosis, Schizophrenia, Alzheimerís, Parkinsonís disease, and other CNS indications)
Paths for regulatory approval


Scientific organizer
s

Giovanni Frisoni IRCCS Fatebenefratelli, Brescia, Italy 
Andreas Jeromin Banyan Biomarkers, USA
Andy Lockhart GlaxoSmithKline, UK
William Potter formerly Merck, Inc., USA

Confirmed speakers
David Brooks Imperial College London, UK

Marc Cantillon Coalition Against Major Disease, Critical Path, USA

Steven Carr Broad Institute, USA

Rong Chen Stanford University, USA
Alexandre Coimbra Merck Research Laboatories, USA

John Collinge, UCL, UK
Ceri Davies, GSK, UK

Daniel Geschwind UCLA, USA
Maria Isaac EMA, UK
Chi-Ming Lee AstraZeneca, USA

Kenneth Marek, The Institute for Neurodegenerative Disorders, USA
Niklas Mattson, Sahlgrenska University, Sweden

Andreas Meyer-Lindenberg Central Institute of Mental Health, Germany
Tim Peakman UK Biobank, UK
Axel Petzold MS Center VUmc Amsterdam, Netherlands
Howard Schulman Caprion Proteomics US, USA

Leslie Shaw U. Penn, USA

Jonathan Schott University College London, UK
Holly Soares BMS, USA

Sarah Tabrizi, University College London, UK
Todd Verdoorn Orasi Medical, Inc, USA
Jeffrey Waring Abbott Laboratories, USA

 

Programme 
Click here to view the Conference programme.                       

 

Accommodation and Registration

Registration is available with no accommodation, or with Single accommodation at the Wellcome Trust Conference Centre.

 

Student

No Accommodation

£462.00

Student

Single Accommodation 

£675.00

Academic

No Accommodation

£562.00

Academic

Single Accommodation

£775.00

Commercial

No Accommodation 

£662.00

Commercial

Single Accommodation 

£875.00

 

REGISTRATION HAS NOW CLOSED DUE TO REACHING MAXIMUM CAPACITY
Please email
lucy.criddle@hinxton.wellcome.ac.uk to be added to the waiting list
 

Abstracts and Posters
Abstracts can be uploaded during the registration process and will be invited as Poster or Oral presentations. You will receive confirmation of the type of presentation after the 24th January 2011.

 


Sponsorship
We would like to acknowledge the generous support from the following organisations:


 

   



     
     

 


 

 Gibbs Building, 215 Euston Road, London NW1 2BE, UK   tel:+44 (0)20 7611 8888   email:contact@wellcome.ac.uk